transformed mouse 3T3 cell double minute 2 ; Mus musculus






362 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 7761100 MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene 1995 May 18 4
2 7916985 Use of representational difference analysis for the identification of mdm2 oncogene amplification in diethylstilbestrol-induced murine uterine adenocarcinomas. Mol Carcinog 1994 Sep 1
3 8649767 Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics. Oncogene 1996 Jun 6 1
4 8761295 Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts. Oncogene 1996 Aug 15 1
5 9548451 Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma. Jpn J Cancer Res 1998 Feb 1
6 9738462 p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment. FEBS Lett 1998 Aug 28 1
7 10222137 An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res 1999 May 1 3
8 10404639 Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin. Int J Biochem Cell Biol 1999 Jun 2
9 10432310 Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem J 1999 Aug 15 3
10 10492400 Constitutive mdmx expression during cell growth, differentiation, and DNA damage. DNA Cell Biol 1999 Sep 1
11 10493945 MDM2 oncogene as a target for cancer therapy: An antisense approach. Int J Oncol 1999 Oct 1
12 10614665 The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells. Endocrinology 2000 Jan 1
13 10643981 Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines. Vet Pathol 2000 Jan 1
14 10710310 DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000 Mar 10 1
15 10713175 Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol 2000 Apr 1
16 10747924 Protection of renal inner medullary epithelial cells from apoptosis by hypertonic stress-induced p53 activation. J Biol Chem 2000 Jun 16 1
17 10856296 DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms. J Biol Chem 2000 Aug 25 7
18 10894886 Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Mutat Res 2000 Jul 20 2
19 11035041 Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis. J Biol Chem 2001 Feb 2 1
20 11237699 Purification of a fragment of MDM2 for production of polyclonal antisera. Protein Expr Purif 2001 Mar 1
21 11284721 Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells. Biochem J 2001 Apr 15 3
22 11359766 Cyclin a-CDK phosphorylation regulates MDM2 protein interactions. J Biol Chem 2001 Aug 10 3
23 11867628 p53 Activation by nitric oxide involves down-regulation of Mdm2. J Biol Chem 2002 May 3 1
24 11894120 Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms. Int J Oncol 2002 Apr 3
25 12135628 Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells. Toxicology 2002 Aug 15 3
26 12589031 Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Mol Cancer Ther 2003 Feb 1
27 12605714 Hepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53. Mol Cancer 2003 Jan 3 1
28 12881704 Rescue of mutant p53 transcription function by ellipticine. Oncogene 2003 Jul 17 2
29 12894226 Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 2003 Jul 31 1
30 12955074 Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase. Oncogene 2003 Sep 4 2
31 14625023 Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations. Neurosci Lett 2003 Dec 11 6
32 14766674 Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 2004 Mar 2
33 15024700 A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance. Histol Histopathol 2004 Apr 1
34 15342939 Exposure of hematopoietic stem cells to benzene or 1,4-benzoquinone induces gender-specific gene expression. Stem Cells 2004 1
35 15385570 Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha. J Biol Chem 2004 Dec 17 1
36 15610030 Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry 2004 Dec 28 3
37 15908939 Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005 Jun 1
38 16014563 MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 2005 Nov 1 2
39 16180010 Involvement of the extracellular signal-regulated protein kinase pathway in phosphorylation of p53 protein and exerting cytotoxicity in human neuroblastoma cells (SH-SY5Y) exposed to acrylamide. Arch Toxicol 2006 Mar 1
40 16208531 Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression. Virchows Arch 2006 Jan 4
41 16244358 Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase. Carcinogenesis 2006 Mar 2
42 16335531 Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2. Mol Cell Biochem 2005 Jun 4
43 16339144 Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem 2006 Feb 10 1
44 16616333 A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell 2006 Apr 1
45 16789731 Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J Med Chem 2006 Jun 29 4
46 16914427 Uteroplacental insufficiency increases p53 phosphorylation without triggering the p53-MDM2 functional circuit response in the IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 2006 Aug 1
47 16949053 Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors. Biochem Pharmacol 2006 Oct 16 1
48 16982679 MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells. Mol Cell Biol 2006 Dec 1
49 17215852 Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 2007 Mar 1
50 17306348 An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol Oncol 2007 May 1